COVID-19: molecular pathophysiology, genetic evolution and prospective therapeutics—a review
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-072X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
COVID-19: molecular pathophysiology, genetic evolution and prospective therapeutics—a review ; day:8 ; month:2 ; year:2021 ; pages:1-15
Archives of microbiology ; (8.2.2021), 1-15
- Urheber
-
Raj, C. T. Dhanya
Kandaswamy, Dinesh Kumar
Danduga, Ravi Chandra Sekhara Reddy
Rajasabapathy, Raju
James, Rathinam Arthur
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00203-021-02183-z
- URN
-
urn:nbn:de:101:1-2021030320425642758821
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Raj, C. T. Dhanya
- Kandaswamy, Dinesh Kumar
- Danduga, Ravi Chandra Sekhara Reddy
- Rajasabapathy, Raju
- James, Rathinam Arthur
- SpringerLink (Online service)
Ähnliche Objekte (12)
Arteriogenesis – molecular regulation, pathophysiology and therapeutics, 1
Normal pressure hydrocephalus : pathology, pathophysiology, diagnostics, therapeutics and clinical course
Emerging Targeted Therapeutics for Genetic Subtypes of Parkinsonism
Genetic drivers of heterogeneity in type 2 diabetes pathophysiology
Genetic drivers of heterogeneity in type 2 diabetes pathophysiology
Unraveling the role of HIF-1α in sepsis: from pathophysiology to potential therapeutics—a narrative review
Modified nucleic acids: replication, evolution, and next-generation therapeutics
The genetic landscape and possible therapeutics of neurofibromatosis type 2
Evolution of Anti-B Cell Therapeutics in Autoimmune Neurological Diseases
IABP: history-evolution-pathophysiology-indications: what we need to know
Transplantation therapeutics
Arithmetical therapeutics
Arteriogenesis – molecular regulation, pathophysiology and therapeutics, 1
Normal pressure hydrocephalus : pathology, pathophysiology, diagnostics, therapeutics and clinical course
Emerging Targeted Therapeutics for Genetic Subtypes of Parkinsonism
Genetic drivers of heterogeneity in type 2 diabetes pathophysiology
Genetic drivers of heterogeneity in type 2 diabetes pathophysiology
Unraveling the role of HIF-1α in sepsis: from pathophysiology to potential therapeutics—a narrative review
Modified nucleic acids: replication, evolution, and next-generation therapeutics
The genetic landscape and possible therapeutics of neurofibromatosis type 2
Evolution of Anti-B Cell Therapeutics in Autoimmune Neurological Diseases
IABP: history-evolution-pathophysiology-indications: what we need to know
Transplantation therapeutics
Arithmetical therapeutics
Arteriogenesis – molecular regulation, pathophysiology and therapeutics, 1
Normal pressure hydrocephalus : pathology, pathophysiology, diagnostics, therapeutics and clinical course
Emerging Targeted Therapeutics for Genetic Subtypes of Parkinsonism
Genetic drivers of heterogeneity in type 2 diabetes pathophysiology
Genetic drivers of heterogeneity in type 2 diabetes pathophysiology
Unraveling the role of HIF-1α in sepsis: from pathophysiology to potential therapeutics—a narrative review
Modified nucleic acids: replication, evolution, and next-generation therapeutics
The genetic landscape and possible therapeutics of neurofibromatosis type 2
Evolution of Anti-B Cell Therapeutics in Autoimmune Neurological Diseases
IABP: history-evolution-pathophysiology-indications: what we need to know
Transplantation therapeutics